Caracterización de la citología cérvicouterina en el Hospital General Docente Comandante Pinares
Keywords:
DIAGNÓSTICO PRECOZ DEL CÁNCER; CÁNCER CERVICOUTERINO; CITOLOGÍA.; EARLY DETECTION OF CANCER; UTERINE CERVICAL NEOPLASMS; CYTOLOGY.; DETECÇÃO PRECOCE DE CÂNCER; NEOPLASIAS DO COLO DO ÚTERO; CITOLOGIA.Abstract
Introduction: the National Program for the Early Diagnosis of Cervical Cancer is aimed at detecting it at the earliest possible stage.
Objective: to characterize the behavior of cervicouterine cytology at the Comandante Pinares General Teaching Hospital.
Methods: An observational, descriptive, cross-sectional study conducted at the Comandante Pinares General Teaching Hospital from January to December 2024. The universe and sample coincided: results of the 10,359 cervicouterine cytologies processed by cytohistopathology during the study period. Statistical analysis was applied to each variable.
Results: the hospital serves 8 health areas in San Cristóbal, Candelaria, and Bahía Honda, Artemisa Province. A total of 2,7 % positive cases were obtained, and 710 samples were deemed non-useful. By municipality, positives ranged between 2,5 % and 2,9 %, while in health areas the range was between 1,2 % and 4,2 %. The most frequent diagnosis was CIN I. No significant differences were found between municipalities; however, there is an association between overall results and health area.
Conclusions: the characterization of cervicouterine cytology establishes that the effectiveness of the National Program for the Early Diagnosis of Cervical Cancer depends not only on the coverage achieved but also on the technical and organizational quality of screening processes. The variability observed among municipalities and health areas requires the design of specific strategies for each territory, while maintaining the national coherence of the program.
Downloads
References
1. Tirado-Reyes RJ, Huape-Abad N, Simental-Gómez NI, Mascareño-Castro SY, Ortiz-Fonseca DS, Robles-Rosas MRI. Validez de la inspección visual con ácido acético frente a citología cervical. Rev Med Inst Mex Seguro Soc [Internet]. 2024 Sep 2 [citado 13/09/2025]; 62(5): 1-10. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC12408104/
2. Ávila MT, Guamán MDCI, Mallitasig SC, Yamunaque YT, Llerena JS, Carrillo CT, et al. Cáncer cérvico uterino escamoso no queratinizante en paciente de 25 años: Reporte de caso clínico. Archivos Venezolanos de Farmacología y Terapéutica [Internet]. 2021 [citado 13/09/2025]; 40(3): 305-309. Disponible en: https://www.redalyc.org/journal/559/55969712013/html/
3. Morales Arauza L, Ruiz Recéndiz M de J, Lozano Zúñiga MM, Leyva Ruiz JC, Paniagua Ramírez S. Conocimientos, Actitudes y Prácticas sobre Citología Cervical en Mujeres de Tuxpan, Michoacán, México. Ciencia Latina [Internet]. 15 de septiembre de 2024 [citado 13/09/2025]; 8(4): 8491-504. Disponible en: https://ciencialatina.org/index.php/cienciala/article/view/13011
4. Álvarez Najae JP, Valderrama-Sanabria ML, Loboa-Rodriguez NJ, Peña-Pita AP. Incertidumbre en la toma de citología cérvico uterina. Rev. cienc. cuidad. [Internet]. 2022 [citado 13/09/2025]; 19(2): 31-39. Disponible en: https://doi.org/10.22463/17949831.3219
5. González Bango MA, Blanco Pereira ME, Ramos Castro G, Martínez Leyva G, Rodríguez Acosta Y, Hernández Ugalde F. Educación sobre cáncer cervicouterino en la adolescencia. Rev.Med.Electrón. [Internet]. 2018 Ago [citado 13/09/2025]; 40(4): 1112-1125. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242018000400017&lng=es
6. Castillo-Ávila IY, Bohórquez-Moreno CE, Hernández-Bello LS. Variables socio-sanitarias asociadas al uso adecuado de la citología cervico-uterina en mujeres del área rural-Cartagena. Duazary. [Internet]. 2019 [citado 13/09/2025]; 16(2): 19-30. Disponible en: https://share.google/9LmVwMwlJa2FQvv6w
7. Vergara-Quintero M del C, Benítez-Dorado MA, Castro-Osorio CJ. Factores ambientales, sociales y comportamentales relacionados con la utilización del servicio de citología cérvico uterina en Circasia-Quindío-Colombia. Ra Ximhai. [Internet]. 2019 [citado 13/09/2025]; 15(1):127-137. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7384605
8. Monier Petiny L de las M. Principales indicadores del Programa de Diagnóstico Precoz del Cáncer Cervicouterino en un hospital de Santiago de Cuba. MEDISAN [Internet]. 2024 Abr [citado 13/09/2025]; 28(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192024000200011&lng=es.
9. Bermejo Bencomo W, Abreu Ruiz G. Premisas para la eliminación del cáncer cervicouterino en Cuba. Rev. cuba. obstet. ginecol. [Internet]. 9 de enero de 2025 [citado 13/09/2025]; 51: e477. Disponible en: https://revginecobstetricia.sld.cu/index.php/gin/article/view/477
10. Organización Panamericana de la Salud. Plan de Acción sobre prevención y el control del cáncer cervicouterino 2018-2030 [Internet]. Washington DC: OPS; 2019 [citado 13/09/2025]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/38574/OPSNMH18051_spa.pdf?sequence=1&isAllowed=y
11. Bermejo Bencomo W, Abreu Ruíz G, Gálvez González AM, Rubio Hernández MC. Acciones de pesquisa para el control del cáncer cervicouterino en Cuba. Infodir [Internet]. 2021 [citado 05/07/2023]; (36): e996. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1996-35212021000300016&lng=es.
12. Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticos de Salud. Anuario Estadístico de Salud 2023 [Internet]. La Habana: MINSAP; 2024 [citado 24/11/2023]. Disponible en: https://files.sld.cu/dne/files/2024/09/Anuario-Estad%c3%adstico-de-Salud-2023-EDICION-2024.pdf
13. González García N. Diagnóstico molecular del virus del papiloma humano: medicina de precisión en la pesquisa del cáncer cérvico uterino en Cuba. Rev. cubana Hematol Inmunol Hemoter [Internet]. 2022 Sep [citado 13/09/2025]; 38(3): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892022000300015&lng=es
14. Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ [Internet]. 2018 Dec 5 [citado 13/09/2025]; 363: k4823. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30518635/
15. Wang J, Elfström KM, Dillner J. Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden. Lancet Public Health [Internet]. 2024 Nov [citado 13/09/2025]; 9(11): e886-e895. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39486904/
16. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin [Internet]. 2020 [citado 13/09/2025]; 70(5):321-346. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32729638/
17. Carrillo Calzadilla Y, Trujillo Martínez N. Referenciación de enfermería en el Programa Detección Precoz del Cáncer Cervicouterino. Rev Cubana Enfermer [Internet]. 2024 [citado 13/09/2025]; 40. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03192024000100025&lng=es.
18. Estrada Fernández I, Cepero Ravelo M, Quesada Sanabria RM. Estrategia educativa para prevenir el cáncer cervicouterino. Medimay [Internet]. 29 de junio de 2023 [citado 13/09/2025]; 30(2):150-7. Disponible en: https://revcmhabana.sld.cu/index.php/rcmh/article/view/2282
19. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis [Internet]. 2020 [citado 13/09/2025]; 24(2):102-131. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32243307/
20. Fernández-Deaza G, Caicedo-Martínez M, Serrano B, Roura E, Castillo JS, De Sanjosé S, et al. Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges. Salud Publica Mex [Internet]. 2022 Jul 8 [citado 13/09/2025]; 64(4, jul-ago): 415-423. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36130384/
21. Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Hernández-Ávila M, Salmerón J, García-Carrancá A. Prevalence of HPV, cytological abnormalities, and impact of the HPV vaccine in Mexico: a nationwide study of 596,944 women. Lancet Reg Health Am [Internet]. 2025 [citado 13/09/2025]; 48: 101156. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40657432/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gigdys Esther Castro Álvarez, Bárbara Dayana López González, Marlín Hernández Barrios, Maritza Alonso Pérez , Joel Ramón Sánchez Portela
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
